Merck KGaA is in the investment-grade market Tuesday, a day after holding investor calls, to help fund its $3.9 billion ...

Immunome's varegacestat shows promising efficacy in desmoid tumors, with phase 3 topline data expected by 2025-end. Read why ...

German drugmaker Merck KGaA on Thursday joined peers in saying it was considering distribution models that serve U.S.

Net profit rose in the second quarter compared to the same period of the previous year for German science and technology ...

Germany's Merck KGaA on Thursday raised its full-year operating earnings guidance, excluding the effect of harsh foreign ...

XTRA:MRK 1 Year Share Price vs Fair Value Explore Merck KGaA's Fair Values from the Community and select yours ...

Merck has announced the acquisition of SpringWorks, which is expected to close this year, for an enterprise value of EUR 3 billion. While the deal appears expensive at an 18 times price/sales multiple ...

Germany’s Merck KGaA (MRK: DE) has reported second quarter earnings that missed analyst expectations. The life sciences company’s earnings before interest, taxes, depreciation and amortization (EBITDA ...

North America Leads Today, Asia Pacific to Record Fastest GrowthThe global high throughput screening market, valued at ...

Merck Foundation and Nigeria First Lady meet to Build Healthcare Capacity, Support girl education and Break Infertility ...

Hexyl Acetate Market UK CAGR rises from 2.5% to 3.8% by 2035, driven by natural fragrances, premium skincare, body sprays, and innovative f ...